Maxify Pharma — Why Most Investors Don't Come Close to Earning Average Returns
Introducing Maxify Pharma, a retail product investing exclusively in pharma stocks, built with Research Delta Advisors.
Tejas Shah
Proprietor of Silicon One and Silicon Systems, AMFI-registered Mutual Fund Distributor since 2004, based in Vadodara.
The most frequent question clients ask is: "Is it a good time to invest?" When markets are down, investors worry and want to wait. When markets are up, they worry about buying just before a correction. When markets go sideways, they wait for some other reason. As Peter Lynch once said: there is always something to worry about.
A pharma-focused offering
Silicon One has roped in Research Delta Advisors, a boutique investment advisory focused on the Indian pharmaceutical sector, to bring out "Maxify Pharma" — a long-term wealth creation solution investing only in pharma stocks. Research Delta's founder has roughly 17 years of experience researching the sector, advising pharma companies on strategic initiatives and mutual fund managers on their pharma investments.
We look forward to seeing you invest with us. Happy investing! — Tejas Shah, Managing Partner, Silicon One.
